Document Detail


Variation in the glucocorticoid receptor gene (NR3C1) may be associated with corticosteroid dependency and resistance in children with Crohn's disease.
MedLine Citation:
PMID:  21633323     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: In pediatric onset of Crohn's disease (CD), corticosteroid dependency (approximately 40%) and resistance (approximately 10%) are significant clinical problems. Given the known effects of the glucocorticoid receptor (GR/NR3C1) gene in corticosteroid metabolism, we investigated whether variation in the gene was associated with corticosteroid response. METHODS: A retrospective cohort study was carried out including patients with CD diagnosed before 18 years and treated with a first course of corticosteroids in two Canadian tertiary pediatric gastroenterology clinics. DNA was obtained from blood or saliva. Tagging single nucleotide polymorphisms (SNPs) and functionally important SNPs were genotyped. Allelic, genotype, and haplotype associations between the glucocorticoid receptor SNPs and response to corticosteroids were examined. RESULTS: A total of 296 corticosteroid-resistant, corticosteroids-dependent, and corticosteroid-responsive patients with CD were studied. Of the 12 SNPs examined, four markers, rs6196 [odds ratio (OR)=2.03; 95% confidence interval (CI): 1.03-4.0; P=0.042], rs7701443 (OR=3.43; 95% CI: 1.79-6.57; P=0.042), rs6190 (OR=4.84; 95% CI: 1.70-13.80; P=0.003), and rs860457 (OR=3.43; 95% CI: 1.79-6.57; P<0.001) were associated at the allelic level with corticosteroid resistance. Haplotype analysis of four associated markers revealed associations between two haplotypes and corticosteroid resistance (P values of 0.046 and 0.001). Three SNPs, rs10482682 (OR=1.43; 95% CI: 0.99-2.08; P=0.047), rs6196 (OR=0.55; 95% CI: 0.31-0.95; P=0.024), and rs2963155 (OR=0.64; 95% CI: 0.42-0.98; P=0.039), showed associations under an additive model, whereas rs4912911 (OR=0.37; 95% CI: 0.13-1.00; P=0.03) and rs2963156 (OR=0.32; 95% CI: 0.07-1.12; P=0.047) showed associations under a recessive model with corticosteroid dependence. Two five-marker haplotypes were associated with corticosteroid dependence (P values 0.002 and 0.004). CONCLUSION: Our results suggest that variations in the GR/NR3C1 gene are associated with corticosteroid resistance and dependency in pediatric-onset CD. Studies are required to replicate these findings and to identify the potentially relevant variants.
Authors:
Alfreda Krupoves; David Mack; Colette Deslandres; Ernest Seidman; Devendra K Amre
Related Documents :
20345823 - Genetics of male nuptial colour divergence between sympatric sister species of a lake v...
15696753 - Multivariate quantitative genetics and the lek paradox: genetic variance in male sexual...
19083013 - Discovery of paragonimus westermani in vietnam and its molecular phylogenetic status in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-31
Journal Detail:
Title:  Pharmacogenetics and genomics     Volume:  -     ISSN:  1744-6880     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-6-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101231005     Medline TA:  Pharmacogenet Genomics     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
aResearch Centre, Sainte-Justine Hospital bDepartments of Preventive and Social Medicine cPaediatrics, University of Montreal dDivision of Gastroenterology, Department of Medicine, McGill University Health Centre, Montreal, Quebec eDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment.
Next Document:  Gene transfer for ischemic heart failure in a preclinical model.